COVID-19 vaccines in patients with urothelial cancers receiving immune checkpoint inhibitors.

被引:0
|
作者
Gilbert, Danielle
Hu, Junxiao
Lam, Elaine T.
机构
[1] Univ Colorado, Sch Med, Aurora, CO USA
[2] Univ Colorado, Ctr Canc, Aurora, CO USA
[3] Univ Colorado, Ctr Comprehens Canc, Aurora, CO USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
491
引用
收藏
页数:1
相关论文
共 50 条
  • [1] COVID-19 vaccines in patients with solid tumor cancers receiving immune checkpoint inhibitors
    Gilbert, Danielle
    Hu, Junxiao
    Lam, Elaine T.
    CANCER RESEARCH, 2023, 83 (07)
  • [2] Safety of COVID-19 vaccines in subjects with solid tumor cancers receiving immune checkpoint inhibitors
    Gilbert, Danielle
    Hu, Junxiao
    Medina, Theresa
    Kessler, Elizabeth R.
    Lam, Elaine T.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
  • [3] Risk of COVID-19 in Patients with Cancer Receiving Immune Checkpoint Inhibitors
    Klebanov, Nikolai
    Pahalyants, Vartan
    Murphy, William S.
    Theodosakis, Nicholas
    Zubiri, Leyre
    Klevens, R. Monina
    Kwatra, Shawn G.
    Lilly, Evelyn
    Reynolds, Kerry L.
    Semenov, Yevgeniy R.
    ONCOLOGIST, 2021, 26 (05): : E898 - E901
  • [4] IMPACT OF COVID-19 ON CANCER PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS
    Tyan, Kevin
    Bui, Ai-Tram
    Giobbie-Hurder, Anita
    Klein, Isaac
    Manos, Michael
    Zubiri, Leyre
    Reynolds, Kerry
    Grover, Shilpa
    Weinhouse, Gerald
    Ott, Patrick
    LeBoeuf, Nicole
    Rahma, Osama
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A296 - A298
  • [5] Infections in patients receiving immune checkpoint inhibitors.
    Sae-Tia, Sutthichai
    Naidoo, Jarushka
    Mehta, Seema
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [6] The impact of COVID-19 mRNA vaccines on immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors
    Guo, Mengni
    Ahmed, Zohaib
    Phuong Nguyen
    Zaidi, Kashaf
    Itzkowitz, Raphael
    Chong, Esther G.
    Castillo, Dani Ran
    Huynh Le Cao
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] mRNA-based COVID-19 vaccines appear not to increase immune events in cancer patients receiving immune checkpoint inhibitors
    Yekeduz, Emre
    Ayasun, Ruveyda
    Koksoy, Elif Berna
    Utkan, Gungor
    Urun, Yuksel
    Akbulut, Hakan
    FUTURE VIROLOGY, 2021, 16 (09) : 583 - 585
  • [8] COVID-19 VACCINATION IN PATIENTS WITH RENAL CANCER OR MELANOMA RECEIVING IMMUNE CHECKPOINT INHIBITORS
    Hwang, Joyce
    Dzimitrowicz, Hannah
    Shah, Riddhishkumar
    Ashcraft, Kathleen
    George, Daniel
    Salama, April
    Zhang, Tian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A655 - A655
  • [9] COVID-19 Outcomes in Patients with Cancer Receiving Immune Checkpoint Inhibitors: A Systematic Review
    Ruiz, Juan I.
    Lopez-Olivo, Maria A.
    Geng, Yimin
    Suarez-Almazor, Maria E.
    JOURNAL OF IMMUNOTHERAPY AND PRECISION ONCOLOGY, 2023, 6 (02) : 103 - 110
  • [10] COVID-19 Outcomes in Stage IV Cancer Patients Receiving Immune Checkpoint Inhibitors
    Mengni Guo
    Jieying Liu
    Shuntai Zhou
    James Yu
    Zohaib Ahmed
    Sarfraz Ahmad
    Manoucher Manoucheri
    Mark A. Socinski
    Tarek Mekhail
    Vincent Hsu
    SN Comprehensive Clinical Medicine, 4 (1)